• Apixaban was associated with a lower risk of stroke/SE and MB compared to warfarin. Additionally, compared with warfarin, dabigatran patients had a lower risk of MB and a similar risk of stroke/SE while rivaroxaban patients had a lower risk of stroke/SE and a similar risk of MB
  • NOACs were associated with a varying risk of stroke/SE and MB compared to warfarin and among each other